Australian Type 2 Diabetes Risk (AUSDRISK) Assessment Tool
Why Use
Includes only non-invasive variables. Provides objective score to help support recommendations of lifestyle modification to patients by primary care physicians. In identified high-risk patients, enables further investigation and appropriate management of risk and lifestyle factors to prevent the development of diabetes. In Australia, AUSDRISK score ≥12 is a prerequisite for physician access to Medicare items for health assessment of patients in the 40-49 age group.
When to Use
Primary care lifestyle screening for adults ≥25 years of age.
Formula
Pearls / Pitfalls
The Australian Type 2 Diabetes Risk (AUSDRISK) Assessment Tool identifies Australian adults at high risk for developing diabetes based on demographic, lifestyle, and simple anthropometric measures. Targeted for use in primary care screening. Enables identification of high risk individuals for focused lifestyle counseling and/or further investigation. Developed specifically for the Australian population but has allowance for ethnicity and country of birth, so it may have validity in other countries with similar demographics. Has been validated in a separate study examining an external cohort of Dutch patients. May overestimate risk in patients <25 years. Some versions of the AUSDRISK eliminate BMI, but the authors found that it resulted in a loss of discriminatory power.
Management
In Australia, patients with scores ≥12 should be investigated for possible diabetes and enrolled for advice regarding diet, weight control, and exercise. Diagnostic criteria for diabetes (Australia): Fasting blood glucose (FBG) ≥7.0 mmol/L, confirmed by a second reading on a separate day OR Oral glucose tolerance test (OGTT) showing FBG ≥7.0 mmol/L or 2-hour blood glucose ≥11.1mmol/L OR Hemoglobin A1c (HgbA1c) ≥48 mmol/mol (6.5%) on two separate occasions.
Critical Actions
Monitor for symptomatic diabetes (e.g. polyuria, polydipsia, loss of sensation).
More Information
AUSDRISK Score 5-year Risk* of Type 2 DM <5 1 in 100 6-8 1 in 50 9-11 1 in 30 12-15 1 in 14 16-19 1 in 7 >20 1 in 3 May overestimate risk in patients <25 years old and may underestimate risk in Aboriginal and Torres Strait Islanders. From General Practice Management Guidelines of Type 2 DM, Royal Australian College of General Practitioners 2016 .